Skip to content

Author

Hai-Feng Zhang

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Stigmasterol Ameliorates Pulmonary Hypertension by Suppressing the CCL5/CCR5 Signaling Pathway: Taurocholic Acid as a Downstream Mediator.

BACKGROUND Pulmonary hypertension (PH) is a devastating disease characterized by irreversible pulmonary vascular remodeling (PVR), ultimately culminating in right ventricular failure and death. Although previous studies have demonstrated that stigmasterol (STG) reduces cholesterol levels and prevents cardiovascular dis...

Yuan Tang, Yan-Ping Shi, Meng-Ting Wang et al. · 0 citations
Review Open access Sep 2026

Residual Apolipoprotein B Elevation Despite PREVENT-Guided LDL-C Goal Attainment Among Adults Without Known ASCVD.

BACKGROUND Low-density lipoprotein cholesterol (LDL-C) goal attainment is central to primary atherosclerotic cardiovascular disease (ASCVD) prevention, but LDL-C may not fully reflect the burden of apolipoprotein B (ApoB)-containing atherogenic particles. The prevalence and clinical correlates of residual ApoB elevatio...

Yan-Ping Shi, Yuan Tang, Meng-Ting Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.